SMS Pharmaceuticals Limited's market cap is currently ₹17.35B. The company's EPS TTM is ₹7.009; its P/E ratio is 29.24; and it has a dividend yield of 0.20%. SMS Pharmaceuticals Limited is scheduled to report earnings on February 5, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	₹ 7.09B	₹ 5.22B	₹ 5.15B	₹ 5.61B	₹ 4.07B
Gross Profit	₹ 2.11B	₹ 1.29B	₹ 1.81B	₹ 1.81B	₹ 1.27B
Operating Income	₹ 1.34B	₹ 272.64M	₹ 821.77M	₹ 988.63M	₹ 580.09M
EBITDA	₹ 1.20B	₹ 593.89M	₹ 1.20B	₹ 1.25B	₹ 850.33M
Net Income	₹ 498.26M	₹ -70.59M	₹ 622.20M	₹ 625.27M	₹ 315.74M
Balance Sheet
Cash & Short-Term Investments	₹ 361.16M	₹ 140.71M	₹ 465.83M	₹ 404.23M	₹ 95.44M
Total Assets	₹ 10.34B	₹ 8.80B	₹ 8.60B	₹ 8.12B	₹ 6.08B
Total Debt	₹ 2.81B	₹ 2.54B	₹ 2.63B	₹ 2.55B	₹ 1.57B
Net Debt	₹ 2.45B	₹ 2.47B	₹ 2.17B	₹ 2.14B	₹ 1.48B
Total Liabilities	₹ 4.98B	₹ 4.19B	₹ 3.89B	₹ 4.02B	₹ 2.60B
Stockholders' Equity	₹ 5.36B	₹ 4.61B	₹ 4.70B	₹ 4.11B	₹ 3.48B
Cash Flow
Free Cash Flow	₹ -20.35M	₹ -74.71M	₹ 129.86M	₹ -612.96M	₹ -30.22M
Operating Cash Flow	₹ 501.25M	₹ 224.50M	₹ 402.34M	₹ 904.53M	₹ 397.12M
Investing Cash Flow	₹ -520.72M	₹ -296.86M	₹ -271.53M	₹ -1.52B	₹ -425.64M
Financing Cash Flow	₹ 306.79M	₹ -319.69M	₹ -69.21M	₹ 920.18M	₹ -24.02M

Currency in INR

SMS Pharmaceuticals Limited Earnings and Revenue History

Income Statement >

SMS Pharmaceuticals Limited Debt to Assets

Balance Sheet >

SMS Pharmaceuticals Limited Cash Flow

Cash Flow >

SMS Pharmaceuticals Limited Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing